Redo Cardiac Surgery
Conditions
Keywords
Redo cardiac surgery, Outcome
Brief summary
This study aims to investigate the prognostic significance of baseline characteristics for patients undergoing redo cardiac surgery.
Detailed description
Redo cardiac surgery is associated with an increased risk of postoperative morbidity and mortality. Patients undergoing redo cardiac surgery are becoming increasingly complex due to multiple comorbidities, adherence of mediastinal structures to the undersurface of the sternum as well as the spatial location of patent bypass grafts relative to the route of entry. Association estimates between baseline characteristics and outcomes in those cohort are imprecise. The aim of this study is to identify prognostic factors associated with redo cardiac surgery which may help physicians predict clinical outcomes and guide their treatment decision.
Interventions
PROCEDURERedo cardiac surgery
Redo cardiac surgery is technically challenging due to scarring of tissues resulting in loss of tissue planes, adhesions, multiple comorbid factors and risk of injury during re-entry.Suggested techniques in coronary artery surgery with a left internal mammary artery include routing the graft through a slit in the pericardium to minimize the possibility of adherence to the sternal table.
Sponsors
Shanghai Zhongshan Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Patients undergoing redo cardiac surgery
Exclusion criteria
* Age \<18 years; * Patients with a DNR order or do not escalate care order.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 28-day mortality | 28 days | Death from any cause at 28 days |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| 60- and 90-day mortality | 60 days and 90 days | Death from any cause at 60- and 90-days |
Other
| Measure | Time frame | Description |
|---|---|---|
| Length of stay in the ICU | up to 90 days | the length of stay in the ICU |
| Length of stay in the hospital | up to 90 days | the length of stay in the hospital |
| Percentage of participants with adverse events | up to 90 days | Adverse events includes haemorrhage; need for intraoperative/postoperative intra-aortic balloon pumping (IABP); prolonged intubation; acute kidney injury or need for continuous renal replacement therapy (CRRT); poor neurological outcome; infection events |
Countries
China
Outcome results
None listed